An experimental RNA-based therapy shows promise for ALS by preventing TDP-43 protein clumping. The therapy halted motor neuron loss in mouse models. Researchers hope to one day move the treatment to ...
The cover of Aging-US Volume 17, Issue 12, features Figure 5 from the research paper, titled "A combination of differential expression and network connectivity analyses identifies a common set of RNA ...
Misshapen proteins cause a mess of trouble—particularly in neurodegenerative diseases. But a new study suggests it's possible ...
A University of California, Irvine-led research team has discovered intricate molecular mechanisms driving the RNA processing defects that lead to Huntington's disease and link HD with other ...
How do cells ensure that the "blueprints" of genetic information-RNA are accurate and intact before they are exported from the nucleus to the cytoplasm for protein production? A study led by Professor ...
Quotient Sciences, a CDMO, reports that it has installed Centillion’s™ Biofoundry-in-a-Box (BiaB™), a multi-product GMP platform technology for end-to-end RNA manufacture. BiaB is a modular, ...
UC Irvine researchers conducted a study to better understand the molecular basis of amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder in which patients lose the ability to move, ...
Scientists have uncovered an unexpected way cells can generate cancer-driving proteins—by cutting RNA into shorter, functional fragments rather than following the standard blueprint. This process, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results